Market Tracker

03/27 6:01pm ET

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

128.78
Delayed Data
As of Mar 27
 +13.23 / +11.45%
Today’s Change
55.04
Today|||52-Week Range
133.54
+42.46%
Year-to-Date

Today’s Trading

Previous close115.55
Today’s open125.00
Day’s range123.05 - 133.54
Volume6,370,724
Average volume (3 months)1,515,755
Market cap$20.5B
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+28.13%
Earnings growth (this year)-142.21%
Earnings growth (next 5 years)+12.50%
Revenue growth (last year)+36.76%
P/E ratioNM
Price/Sales17.64
Price/Book12.57

Competitors

 Today’s
change
Today’s
% change
PCYCPharmacyclics Inc+0.19+0.07%
ZTSZoetis Inc+0.11+0.24%
PRGOPerrigo Company PLC+1.65+1.00%
INCYIncyte Corp+5.16+5.78%
Data as of 4:03pm ET, 03/27/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)-$0.52
Annual revenue (last year)$750.0M
Annual profit (last year)-$134.0M
Net profit margin-17.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts